The Patent Version of Righthaven
by Pamela Chestek • October 23, 2017 • patent • 0 Comments
The news has been abuzz with Allergan, Inc,’s assignment of the patents in the highly lucrative “Restasis” dry-eye drug to the Saint Regis Mohawk Tribe and in turn receiving an exclusive license back. The transfer was so that the validity of the patents could not be challenged in an inter partes review because of...
Read more →